Acessibilidade / Reportar erro

Use of pharmaceutical nanotechnology for the treatment of leishmaniasis

Abstract

INTRODUCTION:

Leishmaniasis is a global public health concern. Currently available treatments are associated with considerable side effects. The use of nanotechnology has shown promise for improving efficacy and bioavailability and minimizing side effects.

METHODS:

This study investigated available literature, including patents and scientific articles, to identify advances in the use of nanotechnology for the treatment of leishmaniasis.

RESULTS:

Our findings revealed a stable number of patents and scientific articles published over the past five years.

CONCLUSIONS:

There is a need to intensify research on the use of nanotechnology for the treatment of leishmaniasis.

Keywords:
Leishmaniasis; Drugs; Nanotechnology; Treatment

Sociedade Brasileira de Medicina Tropical - SBMT Sociedade Brasileira de Medicina Tropical - SBMT, Núcleo de Medicina Tropical – UnB, Sala 43C – 70904-970, E-mails: rsbmt@uftm.edu.br | artes.rsbmt@gmail.com | sbmt@sbmt.org.br , WhatsApp: SBMT (61) 9.9192-6496, WhatsApp: RSBMT (34) 9.9996-5807 - Brasília - DF - Brazil
E-mail: rsbmt@uftm.edu.br